Status:
COMPLETED
Omega-3 Fatty Acids in Adolescent Depression
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
National Center for Research Resources (NCRR)
Conditions:
Adolescent Depression
Eligibility:
All Genders
12-19 years
Phase:
PHASE2
Brief Summary
Aim. To provide preliminary data about the efficacy of omega-3FA in the treatment of adolescent MDD. To address this aim, a 10-week double blind, placebo-controlled study of omega-3FA, using a flexibl...
Detailed Description
Title: Omega-3 Fatty Acids in Adolescents with Depression NOTE: No individual will be advised to terminate ongoing treatment. If adolescents have been in psychotherapy prior to their entry in the stu...
Eligibility Criteria
Inclusion
- Age: 12-19
- Depressed with DSM-IV diagnosis of MDD
- Duration of depressive episode greater than 6 weeks
Exclusion
- Current or past DSM-IV-TR bipolar, schizophrenia, psychosis, pervasive developmental disorder (PDD), and Tourette's disorder.
- Current diagnosis of eating, panic, conduct, obsessive compulsive, post traumatic stress, and/or substance-related disorders (other than nicotine).
- Adolescents who present with current suicidal ideation with intent or plan, or who may pose a danger to themselves.
- Current antidepressant treatment, or taken within 60 days prior to enrollment
- Neuroleptics taken within 90 days prior to enrollment
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT00312897
Start Date
December 1 2005
End Date
June 1 2013
Last Update
April 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029